Kubota Pharmaceutical Holdings Co 4596.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4596.T. It has been listed since 6 December 2016. In the fiscal year to 31 December 2025, it reported revenue of ¥21.3m and a net loss of ¥676.3m. At that date it held total assets of ¥1.98bn and shareholders' equity of ¥1.81bn.

Kubota Pharmaceutical Holdings Co. Ltd. operates as a holding company which provides the management of its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To. The company went IPO on 2016-12-06. Its subsidiaries are mainly engaged in discovering and developing drug candidates to treat and slow the progression of sight-threatening ophthalmic diseases. The firm operates pharmaceutical development segment. The company focuses on the development of oral formulation for age-related macular degeneration (AMD), glaucoma and dry eye syndrome.

Figures and description from our data supplier, not checked against the company's own report.

• Dr. Ryo KubotaChairman, President, Chief Executive Officer, Representative Executive Officer, Chairman, President & CEO of Subsidiary, Director, since 2015
• Mr. Mikio FukaiChief Financial Officer, Chief Operating Officer, Executive Officer, Director, since 2022
• Ms. Iyo IchikawaDirector, since 2021
• Mr. Shintaro AsakoIndependent Director
• Mr. Masaaki FujiwaraIndependent Director
• Mr. Tsutomu HoriuchiIndependent Director
• Mr. Yoshizaki KoichiroIndependent Director
• Ms. Emiko MakiIndependent Director
• Mr. Yuki NakagawaIndependent Director
• Mr. Futoshi ShibuyaIndependent Director
• Mr. Shingo TsudaIndependent Director
• Mr. Koichiro YoshizakiIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.